Chem. J. Chinese Universities ›› 2017, Vol. 38 ›› Issue (6): 1059.doi: 10.7503/cjcu20160797

• Organic Chemistry • Previous Articles     Next Articles

Design, Synthesis and Biological Evaluation of Thrombin Inhibitors with 1,2,3,4-Tetrahydrobenzo[4,5]imidazo[1,2-a]pyrazine Nucleus

CHEN Dongxing1, SHI Jinyu2, CHEN Qiufang2, ZHANG Rui2, GONG Guoqing2, XU Yungen1,2,*(), ZHU Qihua1,2,*()   

  1. 1. Jiangsu Key Laboratory of Drug Design and Optimization, Nanjing 210009, China
    2. School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China
  • Received:2016-11-16 Online:2017-06-10 Published:2017-05-23
  • Contact: XU Yungen,ZHU Qihua E-mail:xyg@cpu.edu.cn;zhuqihua@cpu.edu.cn
  • Supported by:
    † Supported by the National Natural Science Foundation of China(No. 21272277) and the Outstanding Scientific and Technological Innovation Team Projects of Jiangsu Province of China(2015).

Abstract:

Compound 1, a new thrombin inhibitor with 1,2,3,4-tetrahydrobenzo[4,5] imidazo[1,2-a]pyrazine nucleus, was selected as lead compound, and fourteen carbamate derivatives derivatives(2a—6a, 2b—6b, 7—10) were designed and prepared. Furthermore, a twin drug(11) was synthesized by coupling compound 1 with 2-hydroxymethyl-3,5,6-trimethylpyrazine(HTMP). The structures of all the target compounds were confirmed by 1H NMR, 13C NMR and HRMS. Preliminary biological activity test results indicated that all of the tested compounds exhibit a certain degree of inhibitory effect on thrombin-induced platelet aggregation, among which compound 4b[IC50=(0.11±0.08) μmol/L] show better anti-platelet aggregation activity than dabigatran etexilate[IC50=(0.60±0.05) μmol/L]. The in vivo experimental results in rat venous thrombosis model demonstrated compound 4b can significantly reduce thrombosis in a dose-response manner. Compound 11, which showed weak inhibitory effect on thrombin-induced platelet aggregation, also displayed comparable inhibitory effect on rat venous thrombosis with dabigatran etexilate. The study points out that the enhanced potency of compound 11 may be the synergetic effect of HTMP and compound 1 which are generated by hydrolysis in vivo.

Key words: Benzimidazole, Thrombin inhibitors, Antithrombosis

CLC Number: 

TrendMD: